07:48 | 02/08/2021
His test results came out negative 10 days after his diagnosis and self-isolation at home
COVID-19 treatment updates: Antiviral drug Molnupiravir can block COVID-19 transmission within 24 hours
17:36 | 09/12/2020
In early animal testing, Molnupiravir was found to prevent virus carriers from developing severe symptoms and transmitting the disease.
13:37 | 23/07/2020
The cheap, widely used steroid Dexamethasone has been approved as a second treatment of COVID-19 in Japan. The Japan Ministry of Health's approval comes after a trial in Britain showed the drug reducing death rates in hospitalised patients.
15:30 | 01/06/2020
Russia has the world’s third-highest toll of coronavirus infections after the United States and Brazil, and after almost 50 different vaccine projects, Russia has approved an anti-influenza drug to treat Covid-19 and will start delivering courses of the drug, Avifavir, to hospitals in June.
09:20 | 15/04/2020
As countries across the world are hungry for Coronavirus (COVID-19) drugs to beat the pandemic widespread, experts concerns that the production in huge quantities may struggle with the manufacturing cost matters, Reuters cited experts as saying.
08:05 | 08/04/2020
Coronavirus drugs update: Here are five major coronavirus vaccines and drugs being developed for the treatment of Wuhan coronavirus. coronavirus medicine; corona virus cure; coronavirus cure update
14:01 | 06/04/2020
Japan will boost the reserve of Fujifilm Holding Corp’s Avigan anti-flu drug during this fiscal year aiming to serve as many as 2 million people, Reuters cited a piece of information from a planning document.
Initiated and implemented by the consortium of three international NGOs in Vietnam namely CARE, Plan, and World Vision, in collaboration with local partners, the project aims to enhance inclusive and gender responsive forecast-based early action for effective disaster preparedness in Vietnam.
10:30 | 28/10/2021
10:26 | 28/10/2021
10:23 | 28/10/2021
Wavemaker Partners launches first-of-its-kind climate tech venture builder in SE-Asia, with US$25M target for its first fund
10:00 | 28/10/2021
08:49 | 28/10/2021
08:48 | 28/10/2021